PA
API

PharVision Advisers’s Agora API Stock Holding History

PharVision Advisers’s Portfolio API Stock Details API Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,898
Closed -$38.6K – 67
2026
Q1 		$38.6K Sell
10,898
-64,783
-86% -$275K 0.39% 96
2025
Q4 		$308K Buy
75,681
+49,740
+192% +$183K 0.16% 254
2025
Q3 		$99.1K Buy
+25,941
New +$97.9K 0.06% 624

Other funds holding API

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TGP
TMT General Partner Hong Kong $194M AUM 27.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

PharVision Advisers's API Position: Q2 2026 in Review

PharVision Advisers sold out of Agora (API) in Q2 2026, closing a stake of 10,898 shares — an estimated $38.6K sold.

PharVision Advisers first reported a position in API in Q3 2025 and held it in 3 quarters. The position peaked at $308K in Q4 2025. 58 funds tracked by Wall St. Rank hold API as of Q2 2026.

  • PharVision Advisers reported no remaining Agora position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 10,898 Agora shares in Q2 2026, an estimated $38.6K.
  • PharVision Advisers first reported a position in Agora in Q3 2025 and held it in 3 quarters.
  • PharVision Advisers's Agora position peaked at $308K in Q4 2025.
  • 58 funds tracked by Wall St. Rank held Agora as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.